Department of Clinical Laboratory, The Affiliated Li Huili Hospital, Ningbo University, Ningbo, China.
Front Cell Infect Microbiol. 2024 Aug 15;14:1407219. doi: 10.3389/fcimb.2024.1407219. eCollection 2024.
This study aimed to comprehensively investigate hypervirulent carbapenem-resistant (CR-hvKP) in the Ningbo region. Importantly, we sought to elucidate its molecular characteristics and pathogenic mechanisms. This information will provide evidence-based insights for preventing and controlling nosocomial infections and facilitate improved clinical diagnosis and treatment in this region.
96 carbapenem-resistant strains were collected from the Ningbo region between January 2021 and December 2022. Whole genome sequencing and bioinformatic methods were employed to identify and characterize CR-hvKP strains at the molecular level. The minimum inhibitory concentrations (MICs) of common clinical antibiotics were determined using the VITEK-2 Compact automatic microbiological analyzer. Plasmid conjugation experiments evaluated the transferability of resistance plasmids. Finally, mouse virulence assays were conducted to explore the pathogenic mechanisms.
Among the 96 strains, a single CR-hvKP strain, designated CR-hvKP57, was identified, with an isolation frequency of 1.04%. Whole-genome sequencing revealed the strain to be ST23 serotype with a K1 capsule. This strain harbored three plasmids. Plasmid 1, a pLVPK-like virulence plasmid, carried multiple virulence genes, including , , , , and . Plasmid 2 contained transposable element sequences such as IS15 and IS26. Plasmid 3, classified as a resistance plasmid, harbored the carbapenem resistance gene. Mouse virulence assays demonstrated a high mortality rate associated with CR-hvKP57 infection. Additionally, there was a significant increase in IL-1β, IL-6, and TNF-α levels in response to CR-hvKP57 infection, indicating varying degrees of inflammatory response. Western blot experiments further suggested that the pathogenic mechanism involves activation of the NF-κB signaling pathway.
This study confirms the emergence of hypervirulent CR-hvKP in the Ningbo region, which likely resulted from the acquisition of a pLVPK-like virulence plasmid and a resistance plasmid by the ST23-K1 type . Our findings highlight the urgent need for more judicious use of antibiotics to limit the emergence of resistance. Additionally, strengthening infection prevention and control measures is crucial to minimize the spread of virulence and resistance plasmids.
本研究旨在全面调查宁波地区的高毒力碳青霉烯耐药(CR-hvKP)。重要的是,我们试图阐明其分子特征和发病机制。这些信息将为预防和控制医院感染提供循证见解,并有助于改善该地区的临床诊断和治疗。
2021 年 1 月至 2022 年 12 月期间,从宁波地区采集了 96 株碳青霉烯耐药菌株。采用全基因组测序和生物信息学方法从分子水平鉴定和表征 CR-hvKP 菌株。使用 VITEK-2 Compact 自动微生物分析仪测定常见临床抗生素的最小抑菌浓度(MIC)。质粒接合实验评估了耐药质粒的可转移性。最后,进行小鼠毒力实验以探索发病机制。
在 96 株菌株中,鉴定出一株单一的 CR-hvKP 菌株,命名为 CR-hvKP57,分离频率为 1.04%。全基因组测序显示该菌株为 ST23 血清型,具有 K1 荚膜。该菌株携带三个质粒。质粒 1 为 pLVPK 样毒力质粒,携带多个毒力基因,包括 、 、 、 和 。质粒 2 包含转座元件序列,如 IS15 和 IS26。质粒 3 被归类为耐药质粒,携带 基因。小鼠毒力实验表明,CR-hvKP57 感染导致高死亡率。此外,CR-hvKP57 感染后,IL-1β、IL-6 和 TNF-α 水平显著升高,表明存在不同程度的炎症反应。Western blot 实验进一步表明,发病机制涉及 NF-κB 信号通路的激活。
本研究证实了高毒力 CR-hvKP 在宁波地区的出现,这可能是由于 ST23-K1 型获得了 pLVPK 样毒力质粒和 基因。我们的研究结果强调了更明智地使用抗生素以限制耐药性出现的迫切需要。此外,加强感染预防和控制措施对于最大限度地减少毒力和耐药质粒的传播至关重要。